Today's Disclosures
Browse disclosures by date and follow changes in the stocks you care about.
Disclosure list
151 total
20261027000389
Remed corrected the payment date of its KRW 10 billion convertible bond issue for working capital to November 4, 2026.
20261027900663
Bitplanet corrected its notice, moving the extraordinary general meeting to 2026-11-24 at 10:00 and adding director elections to the charter amendment agenda.
Hanwha Plus No 5 Special Purpose Acquisition Company
20261027000380
Solis will absorb Hanwha Plus No.5 SPAC in a merger, and the corrected merger date is December 29, 2026.
20261027000377
Mezoo acquired a building and land in Wonju from LG H&H for KRW 3.8 billion; the amendment only added attachments.
Share Cancellation
Hanmi Science will retire 448,286 common treasury shares, valued at KRW 9,363,585,341 on a book basis, on November 2, 2026.
20261027800677
Hanmi Science's Q3 2026 consolidated revenue was KRW 362.9 billion, up 5.9% year over year and down 1.4% quarter over quarter; operating profit was KRW 19.2 billion, down 51.3% and 67.6%.}
20261027000379
BK Holdings decided to issue KRW 2 billion of Series 8 private convertible bonds with a conversion price of KRW 2,810, maturing on November 27, 2029.
BK Holdings CO.,LTD.Major
20261027900680
BK Holdings will hold an extraordinary general meeting on November 11, 2026, to vote on an articles amendment and the appointment of inside director Shin Hye-jong.
BK Holdings CO.,LTD.Major
20261027000387
BK Holdings will hold an extraordinary general meeting on November 11, 2026 at 9:00 AM to vote on articles amendments and an inside director appointment.
Report on Large Shareholdings
Kim Myung-hwan and 6 related parties raised their stake in Deokshin EPC from 32.88% to 33.21% through on-market purchases.
Report on Large Shareholdings
Align Partners Asset Management reported that its stake in STIC Investments rose from 7.63% to 8.36%, or 3,242,973 shares.
Curiox Biosystems Co., Ltd.Major
20261027900676
Curiox Biosystems' Q3 2026 consolidated revenue was KRW 1,492 million, up 7.73% year over year and 26.87% quarter over quarter, with an operating loss of KRW 3,960 million.
20261027000375
Daedong corrected the series number of its KRW 6.0 billion private convertible bond from 43 to 60 due to a typo.
Report on Large Shareholdings
Align Partners Asset Management's stake stayed at 10.47% after an off-hours block trade with a related party; shares under contract total 386,083.
Share Cancellation
Hanmi Pharmaceutical, a subsidiary of Hanmi Science, decided to retire 85,316 common treasury shares, with a book value of KRW 28.3 billion, on November 2, 2026.
Don't miss the next one.
Get new disclosures for your watchlist in the app.